PubMed:32829416 / 136-143
The case for re-examining glycosylation inhibitors, mimetics, primers and glycosylation decoys as antivirals and anti-inflammatories in COVID19.
|
projects
Unselected / annnotation | Selected / annnotation | |
|
|
|
The case for re-examining glycosylation inhibitors, mimetics, primers and glycosylation decoys as antivirals and anti-inflammatories in COVID19.
|
Unselected / annnotation | Selected / annnotation | |
|
|
|